These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 34586410)
21. A premature termination mutation in a patient with Lowe syndrome without congenital cataracts: dropping the "O" in OCRL. Pasternack SM; Böckenhauer D; Refke M; Tasic V; Draaken M; Conrad C; Born M; Betz RC; Reutter H; Ludwig M Klin Padiatr; 2013 Jan; 225(1):29-33. PubMed ID: 22915452 [TBL] [Abstract][Full Text] [Related]
23. Novel OCRL1 gene mutations in six Chinese families with Lowe syndrome. Gao Y; Jiang F; Ou ZY World J Pediatr; 2016 Nov; 12(4):484-488. PubMed ID: 27059748 [TBL] [Abstract][Full Text] [Related]
24. Atypical phenotypes and novel OCRL variations in southern Chinese patients with Lowe syndrome. Du R; Zhou C; Chen S; Li T; Lin Y; Xu A; Huang Y; Mei H; Huang X; Tan D; Zheng R; Liang C; Cai Y; Shao Y; Zhang W; Liu L; Zeng C Pediatr Nephrol; 2024 Aug; 39(8):2377-2391. PubMed ID: 38589698 [TBL] [Abstract][Full Text] [Related]
25. The 5-phosphatase OCRL in Lowe syndrome and Dent disease 2. De Matteis MA; Staiano L; Emma F; Devuyst O Nat Rev Nephrol; 2017 Aug; 13(8):455-470. PubMed ID: 28669993 [TBL] [Abstract][Full Text] [Related]
26. Novel OCRL1 mutations in patients with the phenotype of Dent disease. Utsch B; Bökenkamp A; Benz MR; Besbas N; Dötsch J; Franke I; Fründ S; Gok F; Hoppe B; Karle S; Kuwertz-Bröking E; Laube G; Neb M; Nuutinen M; Ozaltin F; Rascher W; Ring T; Tasic V; van Wijk JA; Ludwig M Am J Kidney Dis; 2006 Dec; 48(6):942.e1-14. PubMed ID: 17162149 [TBL] [Abstract][Full Text] [Related]
27. [A case report of genetic analysis in the OCRL1 gene in Lowe syndrome]. Jiang F; Gao Y; Ou ZY Zhonghua Er Ke Za Zhi; 2012 Sep; 50(9):708-9. PubMed ID: 23158824 [No Abstract] [Full Text] [Related]
28. Oculocerebrorenal syndrome of Lowe (OCRL) controls leukemic T-cell survival by preventing excessive PI(4,5)P Chen H; Lu C; Tan Y; Weber-Boyvat M; Zheng J; Xu M; Xiao J; Liu S; Tang Z; Lai C; Li M; Olkkonen VM; Yan D; Zhong W J Biol Chem; 2023 Jun; 299(6):104812. PubMed ID: 37172724 [TBL] [Abstract][Full Text] [Related]
29. Base editing correction of OCRL in Lowe syndrome: ABE-mediated functional rescue in patient-derived fibroblasts. Chen S; Lo CH; Liu Z; Wang Q; Ning K; Li T; Sun Y Hum Mol Genet; 2024 Jun; 33(13):1142-1151. PubMed ID: 38557732 [TBL] [Abstract][Full Text] [Related]
30. The oculocerebrorenal syndrome of Lowe: an update. Bökenkamp A; Ludwig M Pediatr Nephrol; 2016 Dec; 31(12):2201-2212. PubMed ID: 27011217 [TBL] [Abstract][Full Text] [Related]
31. Incomplete cryptic splicing by an intronic mutation of OCRL in patients with partial phenotypes of Lowe syndrome. Nakano E; Yoshida A; Miyama Y; Yabuuchi T; Kajiho Y; Kanda S; Miura K; Oka A; Harita Y J Hum Genet; 2020 Oct; 65(10):831-839. PubMed ID: 32427950 [TBL] [Abstract][Full Text] [Related]
32. Novel OCRL mutations in Chinese children with Lowe syndrome. Zhang YQ; Wang F; Ding J; Yan H; Yang YL World J Pediatr; 2013 Feb; 9(1):53-7. PubMed ID: 23389333 [TBL] [Abstract][Full Text] [Related]
33. A novel OCRL1 mutation in a patient with the mild phenotype of Lowe syndrome. Sugimoto K; Nishi H; Miyazawa T; Fujita S; Okada M; Takemura T Tohoku J Exp Med; 2014 Mar; 232(3):163-6. PubMed ID: 24614960 [TBL] [Abstract][Full Text] [Related]
34. [Investigation and OCRL mutation analysis of a family with oculocerebrorenal syndrome of Lowe]. Shi RM; Bian XH; Li LM; Liu XH Zhongguo Dang Dai Er Ke Za Zhi; 2014 Apr; 16(4):366-9. PubMed ID: 24750831 [TBL] [Abstract][Full Text] [Related]
35. Novel pathogenic OCRL mutations and genotype-phenotype analysis of Chinese children affected by oculocerebrorenal syndrome: two cases and a literature review. Zhang Y; Deng L; Chen X; Hu Y; Chen Y; Chen K; Zhou J BMC Med Genomics; 2021 Sep; 14(1):219. PubMed ID: 34488756 [TBL] [Abstract][Full Text] [Related]
36. OCRL localizes to the primary cilium: a new role for cilia in Lowe syndrome. Luo N; West CC; Murga-Zamalloa CA; Sun L; Anderson RM; Wells CD; Weinreb RN; Travers JB; Khanna H; Sun Y Hum Mol Genet; 2012 Aug; 21(15):3333-44. PubMed ID: 22543976 [TBL] [Abstract][Full Text] [Related]
37. Role of oculocerebrorenal syndrome of Lowe (OCRL) protein in megakaryocyte maturation, platelet production and functions: a study in patients with Lowe syndrome. Egot M; Lasne D; Poirault-Chassac S; Mirault T; Pidard D; Dreano E; Elie C; Gandrille S; Marchelli A; Baruch D; Rendu J; Fauré J; Flaujac C; Gratacap MP; Sié P; Gaussem P; Salomon R; Baujat G; Bachelot-Loza C Br J Haematol; 2021 Mar; 192(5):909-921. PubMed ID: 33528045 [TBL] [Abstract][Full Text] [Related]
38. A 3D Renal Proximal Tubule on Chip Model Phenocopies Lowe Syndrome and Dent II Disease Tubulopathy. Naik S; Wood AR; Ongenaert M; Saidiyan P; Elstak ED; Lanz HL; Stallen J; Janssen R; Smythe E; Erdmann KS Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069732 [TBL] [Abstract][Full Text] [Related]
39. [Analysis of OCRL gene mutation in a male infant with Lowe syndrome]. Chen S; Zhang X; Chen L; Tian Q; Jiang W Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Apr; 31(2):223-7. PubMed ID: 24711037 [TBL] [Abstract][Full Text] [Related]
40. Insights into the Effect of Lowe Syndrome-Causing Mutation p.Asn591Lys of OCRL-1 through Protein-Protein Interaction Networks and Molecular Dynamics Simulations. Acosta-Tapia N; Galindo JF; Baldiris R J Chem Inf Model; 2020 Feb; 60(2):1019-1027. PubMed ID: 31967472 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]